Biotts S.A. raised over EUR 1,5 mln from the Montis Capital Group. The funds will be allocated to the biotechnology startup development – continuation of drug research, team building and commercialization of already owned technologies. Almost half of the funds will be allocated to the new drugs development, PLN 1.5 million for the creation of new […]

Przeczytaj cały artykuł
Talk – Action = Bullshit